0
0
Read Time:10 Second
Alkem Laboratories Limited has informed the Exchange regarding a press release dated September 22, 2025, titled “Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer.”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
